Coronary heart disease secondary prevention antiplatelet agents/anticoagulants: Revision history

11 January 2013

• curprev 14:3114:31, 11 January 2013‎ Prashanthsaddala talk contribs‎ 25,109 bytes −820‎ →‎Sources

10 January 2013

• curprev 21:1921:19, 10 January 2013‎ Michael Maddaleni talk contribs‎ 25,929 bytes −44‎ No edit summary
• curprev 21:1921:19, 10 January 2013‎ Michael Maddaleni talk contribs‎ 25,973 bytes +27‎ /* Antiplatelet Agents and Anticoagulants (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and...

8 January 2013

• curprev 20:5720:57, 8 January 2013‎ Prashanthsaddala talk contribs‎ 25,946 bytes +13‎ No edit summary

14 November 2012

• curprev 18:5918:59, 14 November 2012‎ Esther Lee talk contribs‎ 25,933 bytes +232‎ /* Antiplatelet Agents and Anticoagulants (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and...
• curprev 15:4915:49, 14 November 2012‎ Esther Lee talk contribs‎ 25,701 bytes 0‎ /* Antiplatelet agents and Anticoagulants (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and...
• curprev 15:4915:49, 14 November 2012‎ Esther Lee talk contribs‎ 25,701 bytes +2‎ /* Antiplatelet agents and Anticoagulants (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and...
• curprev 15:3315:33, 14 November 2012‎ Esther Lee talk contribs‎ 25,699 bytes +6,101‎ /* Antiplatelet agents and Anticoagulants (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and...
• curprev 15:1715:17, 14 November 2012‎ Esther Lee talk contribs‎ 19,598 bytes +5,053‎ /* Antiplatelet agents and Anticoagulants (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and...
• curprev 15:0015:00, 14 November 2012‎ Esther Lee talk contribs‎ 14,545 bytes +1,985‎ /* Antiplatelet agents and Anticoagulants (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and...
• curprev 14:5214:52, 14 November 2012‎ Esther Lee talk contribs‎ 12,560 bytes +5‎ →‎antiplatelet agents/anticoagulants

13 November 2012

• curprev 16:5916:59, 13 November 2012‎ Esther Lee talk contribs‎ 12,555 bytes +6,099‎ No edit summary

11 October 2012

• curprev 18:4818:48, 11 October 2012‎ Esther Lee talk contribs‎ 6,456 bytes +5‎ No edit summary
• curprev 16:4316:43, 11 October 2012‎ Esther Lee talk contribs‎ 6,451 bytes +108‎ No edit summary
• curprev 16:4316:43, 11 October 2012‎ Esther Lee talk contribs‎ 6,343 bytes +6,343‎ Created page with "__NOTOC__ {{Coronary heart disease}} {{CMG}} == Overview == ==Type 2 Diabetes Mellitus Management== ===ACC / AHA 2011 Guidelines - Coronary Heart Disease - Secondary Preventi..."